© 2005 European Society of Cardiology
Global and regional myocardial oxygen consumption and blood flow in severe cardiomyopathy with left bundle branch block
a Institute of Molecular Biophysics, Radiopharmacy and Nuclear Medicine, Heart and Diabetes Center North Rhine-Westphalia Georgstr. 11, D-32545 Bad Oeynhausen, Germany
b Department of Cardiology, Heart and Diabetes Center North Rhine-Westphalia Bad Oeynhausen, Germany
* Corresponding author. Tel.: +49 5731 97 1309; fax.: +49 5731 97 2190. E-mail address: olindner{at}hdz-nrw.de
| Abstract |
|---|
Objective: In patients with dilated cardiomyopathy (DCM), left bundle branch block (LBBB) is a common finding. The characteristic feature is an asynchronous septal wall motion and most frequently a delay of the lateral and/or posterior wall segments. With the onset of cardiac resynchronization therapy, there is a focus on the specific pathophysiology of a LBBB. However, quantitative data on regional myocardial oxygen consumption (MVO2) and blood flow (MBF) are missing.
Methods: We studied 31 patients with severe DCM and LBBB (ejection fraction 22.1±7.1%) and 14 patients with mild to moderate DCM without LBBB (ejection fraction 46.7±7.9%). Global and regional MVO2 as well as MBF were determined from a dynamic 11C-acetate positron emission tomography (PET) study.
Results: Global MVO2 and MBF were lower in the DCM group with LBBB than in the control group (P<0.05). Regionally, the LBBB group revealed a higher (P<0.05) MVO2 and MBF in the lateral wall than in the other walls. The control group did not show significant differences between the myocardial walls and demonstrated a smaller variability of the parameters.
Conclusion: DCM patients with LBBB exhibit a more heterogeneous distribution of MVO2 and MBF among the myocardial walls than DCM patients without LBBB. Due to the LBBB associated electromechanical alterations, the highest regional values of MVO2 and MBF are found in the lateral wall.
Key Words: Cardiomyopathy Conduction system Oxygen consumption Blood flow
Received November 24, 2003; Revised February 18, 2004; Accepted July 5, 2004
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
R. A. Tio, A. Dabeshlim, H.-M. J. Siebelink, J. de Sutter, H. L. Hillege, C. J. Zeebregts, R. A.J.O. Dierckx, D. J. van Veldhuisen, F. Zijlstra, and R. H.J.A. Slart Comparison Between the Prognostic Value of Left Ventricular Function and Myocardial Perfusion Reserve in Patients with Ischemic Heart Disease J. Nucl. Med., February 1, 2009; 50(2): 214 - 219. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Valzania, F. Gadler, R. Winter, F. Braunschweig, L.-A. Brodin, P. Gudmundsson, G. Boriani, and M. J. Eriksson Effects of cardiac resynchronization therapy on coronary blood flow: Evaluation by transthoracic Doppler echocardiography Eur J Heart Fail, May 1, 2008; 10(5): 514 - 520. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Thompson, G. Saab, D. Birnie, B. J.W. Chow, H. Ukkonen, K. Ananthasubramaniam, R. A. deKemp, L. Garrard, T. D. Ruddy, J. N. DaSilva, et al. Is Septal Glucose Metabolism Altered in Patients with Left Bundle Branch Block and Ischemic Cardiomyopathy? J. Nucl. Med., November 1, 2006; 47(11): 1763 - 1768. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Donal, C. Leclercq, C. Linde, and J.-C. Daubert Effects of cardiac resynchronization therapy on disease progression in chronic heart failure Eur. Heart J., May 1, 2006; 27(9): 1018 - 1025. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. C. P. Kerckhoffs, O. P. Faris, P. H. M. Bovendeerd, F. W. Prinzen, K. Smits, E. R. McVeigh, and T. Arts Electromechanics of paced left ventricle simulated by straightforward mathematical model: comparison with experiments Am J Physiol Heart Circ Physiol, November 1, 2005; 289(5): H1889 - H1897. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. Gibbons and P. A. Araoz The Year in Cardiac Imaging J. Am. Coll. Cardiol., August 2, 2005; 46(3): 542 - 551. [Full Text] [PDF] |
||||




